• Hannah R Palmer, Jessica M Cottreau, Kevin W Garey, Elizabeth B Hirsch, William L Musick, Vincent H Tam, Rosa F Yeh, and Houston Infectious Diseases Network.
• St. Luke's Episcopal Hospital, Houston, TX, USA.
• Am J Health Syst Pharm. 2010 Aug 1; 67 (15): e34-42.

PurposeSignificant publications on infectious diseases (ID) pharmacotherapy in 2009 are summarized.SummaryOn December 31, 2009, the Houston Infectious Diseases Network amassed a list of articles identified as having a significant impact on ID pharmacotherapy. Articles selected were published between January 1, 2009, and December 31, 2009, in prominent, peer-reviewed journals. Articles were selected based on their perceived potential impact on pharmacy practice in ID, human immunodeficiency virus (HIV), or acquired immune deficiency syndrome (AIDS). A list of 45 articles not related to HIV infection and 17 articles related to HIV infection was distributed to members of the Society of Infectious Diseases Pharmacists (SIDP) via an Internet survey. Members were asked to select the 10 publications (from the list of 45 non-HIV-related articles) that they felt contributed most to ID pharmacotherapy and to select the single most significant publication from the list of 17 articles related to HIV or AIDS. Of the 531 SIDP members surveyed, 100 responded (18.8%). The top 10 articles (9 non-HIV-related and 1 HIV-related) identified from this survey are summarized in this article. Three of the top 10 articles selected from the non-HIV category included new or updated ID guidelines. Summaries of the top articles selected (9 non-HIV-related and 1 HIV-related) from this survey are included.ConclusionDue to the growing number of articles published each year, it is difficult to maintain a current knowledge of significant publications in ID. This review of significant publications in ID pharmacotherapy can be helpful by lessening this burden.

5 keywords...

hide…